Compare ARK Genomic Revolution ETF (ARKG) vs Palo Alto Networks Inc (PANW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Palo Alto Networks Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Palo Alto Networks Inc trades at $325.85 (market cap $265.62B). Which is the better fit depends on your goals.
| ARKG | PANW | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $357.53 |
52-Week Low | $23.09 | $141.67 |
Market Cap | — | $265.62B |
Enterprise Value | — | $264.58B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Palo Alto Networks (PANW) trades at $325.91, down 3.67% today, but maintains strong analyst support with 74% buy ratings and a $334.71 consensus target. The stock shows bullish technical signals with support at $321 and resistance at $347. Recent earnings have consistently beaten expectations, with Q1 2026 EPS of $0.85 surpassing the $0.793 estimate. Revenue growth remains robust, climbing from $5.5B in 2022 to $9.22B in 2025, though valuation multiples appear elevated with a P/E of 283.4.
PANW's outlook is supported by AI-driven cybersecurity demand and platformization strategy, but high valuation and competitive pressures present risks. The company's positive cash flow trends and analyst optimism suggest potential upside, though investors should weigh premium pricing against growth sustainability in a dynamic security market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Palo Alto Networks Inc
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →
